Friday, September 20, 2013 1:33:55 PM
RNA...I know that DD is verboten, but... 
A DeutscheBank analyst who follows the biotech sector closely and Prosensa (RNA) specifically, says there's a good chance that they simply didn't use a high enough dose of the drug in the Phase III test. “Today’s news may suggest getting to market may be harder, but we think they will get there.”
Good company, not a scam. Loaded up in pre-market around 6, bought more at 7, going to hold for awhile.
A DeutscheBank analyst who follows the biotech sector closely and Prosensa (RNA) specifically, says there's a good chance that they simply didn't use a high enough dose of the drug in the Phase III test. “Today’s news may suggest getting to market may be harder, but we think they will get there.”
Good company, not a scam. Loaded up in pre-market around 6, bought more at 7, going to hold for awhile.
All that is needed to make a happy life is within yourself, in your way of thinking. -Marcus Aurelius
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
